Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Yang, Wei ^a   Wei, Jing ^a   Sun, Ting ^a   Liu, Fenju ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Hepatoma; Hypoxia; MiR 210; Radiotherapy

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; MICRORNA 210;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; LIVER CELL CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; RADIATION TOLERANCE; RADIATION, IONIZING; RADIOTHERAPY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84877001540     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-102     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29. 10.3322/caac.20138, 22237781.
3. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022. 10.1002/hep.24199, 3084991, 21374666.
4. Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007, 26:241-248. 10.1007/s10555-007-9056-0, 17440683.
5. Yang W, Sun T, Cao JP, Fan SJ. Hypoxia-Inducible Factor-1α downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and enhances radiosensitivity in chemical hypoxic human hepatoma SMMC-7721 cells. Cancer Biother Radio 2011, 6:565-571.
6. Liu JY, Zhang J, Wang XW, Li Y, Chen YB, Li KC, Zhang J, Yao LB, Guo GZ. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells. Exp Cell Res 2010, 316:1985-1993. 10.1016/j.yexcr.2010.02.028, 20206160.
7. Lan KL, Lan KH, Sheu ML, Chen MY, Shih YS, Hsu FC, Wang HM, Liu RS, Yen SH. Honokiol inhibits hypoxia-inducible factor-1 pathway. Int J Radiat Bio 2011, 87:579-590.
8. Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan M. Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Design 2009, 15:3861-3866.
9. Bushati N, Cohen SM. MicroRNA functions. Annu Rev Cell Dev Biol 2007, 23:175-205. 10.1146/annurev.cellbio.23.090506.123406, 17506695.
10. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136:586-591. 10.1016/j.cell.2009.02.005, 19239879.
11. Huang X, Le QT, Giaccia AJ. MiR-210-micromanager of the hypoxia pathway. Trends Mol Med 2010, 16:230-237. 10.1016/j.molmed.2010.03.004, 3408219, 20434954.
12. Giannakakis A, Sandaltaopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O'Brien-Jenkins A, Katsaros D, Weber BL, Simon C, Coukos G, Zhang L. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 2008, 7:255-264. 10.4161/cbt.7.2.5297, 3233968, 18059191.
13. Zhang Z, Sun H, Dai HY, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, Marszalek JR, Bartz SR, Carleton M, Cleary MA, Linsley PS, Grandori C. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009, 8:2756-2768. 10.4161/cc.8.17.9387, 19652553.
14. Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009, 284:33161-33168. 10.1074/jbc.M109.020925, 2785158, 19721136.
15. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 2009, 10:273-284. 10.1016/j.cmet.2009.08.015, 2759401, 19808020.
16. Pulkkinen K, Malm T, Turunen M, Koistinaho J, Ylä-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo Ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 2008, 582:2397-2401. 10.1016/j.febslet.2008.05.048, 18539147.
17. Yang W, Sun T, Cao J, Liu FJ, Tian Y, Zhu W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 2012, 318:944-954. 10.1016/j.yexcr.2012.02.010, 22387901.
18. Ding SG, Li CG, Lin SR, Yang Y, Liu DH, Han YJ, Zhang Y, Li LN, Zhou LY, Kumar S. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 2006, 37:861-866. 10.1016/j.humpath.2006.02.006, 16784986.
19. Yang W, Sun T, Cao JP, Liu FJ. Survivin downregulation by siRNA/cationic liposome complex radiosensitizes human hepatoma cells in vitro and in vivo. Int J Radiat Bio 2010, 86:445-457.
20. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, Xin H, Sun S. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med 2011, 16:249-259.
21. Yuk CC, Jaideep B, Sang YC, Chandan KS. miR-210: the master hypoxamir. Microcirculation 2012, 19:215-223. 10.1111/j.1549-8719.2011.00154.x, 3399423, 22171547.
22. Stephen YC, Joseph L. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010, 9:1072-1083. 10.4161/cc.9.6.11006, 2912143, 20237418.
23. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, Ragoussis J, Harris AL. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010, 116:2148-2158.
24. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008, 14:1340-1348. 10.1158/1078-0432.CCR-07-1755, 18316553.
25. Foekens JA, Sieuwerts AM, Smid M, Look MP, De Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 2008, 105:13021-13026. 10.1073/pnas.0803304105, 2529088, 18755890.
26. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, Giaccia AJ. Hypoxia-inducible miR-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009, 35:856-867. 10.1016/j.molcel.2009.09.006, 2782615, 19782034.
27. Hurlin PJ, Queva C, Eisenman RN. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 1997, 11:44-58. 10.1101/gad.11.1.44, 9000049.
28. Hurlin PJ, Huang J. The MAX-interacting transcription factor network, Semin. Cancer Biol 2006, 16:265-274.
29. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010, 122:S124-S131. 10.1161/CIRCULATIONAHA.109.928424, 2952325, 20837903.
30. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J Biol Chem 2008, 283:15878-15883. 10.1074/jbc.M800731200, 3259646, 18417479.
31. Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 2011, 301:H1519-H1530. 10.1152/ajpheart.01080.2010, 3197368, 21841015.
32. Xie Q, Lin T, Zhang Y, Zheng J, Bonanno JA. Molecular cloning and characterization of a human AIF-like gene with ability to induce apoptosis. J Biol Chem 2005, 280:19673-19681. 10.1074/jbc.M409517200, 15764604.
33. Timothy JK, Amanda LS, Clary BC, Pere P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1α stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol 2011, 31:2696-2706. 10.1128/MCB.01242-10, 3133367, 21555452.